Skip to main content
. 2023 Jan 30;19(1):2169531. doi: 10.1080/21645515.2023.2169531

Figure 4.

Figure 4.

Forest plot of comparison of (a) OS, (b) PFS, and (c) adverse events of grade 3 or higher between immunotherapy and chemotherapy.